Inappropriate cervical injection of radiotracer for sentinel node mapping in a uterine cervix cancer patient: importance of lymphoscintigraphy and blue dye injection

Document Type : Case report


1 Women’s Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

2 Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran


Herein, we report a case of sentinel lymph node mapping in a uterine cervix cancer patient, referring to the nuclear medicine department of our institute. Lymphoscintigraphy images showed inappropriate intra‐cervical injection of radiotracer. Blue dye technique was applied for sentinel lymph node mapping, using intra‐cervical injection of methylene blue. Two blue/cold sentinel lymph nodes, with no pathological involvement, were intra‐operatively identified, and the patient was spared pelvic lymph node dissection. The present case underscores the importance of lymphoscintigraphy imaging in sentinel lymph node mapping and demonstrates the added value of blue dye injection in selected patients. It is suggested that preoperative lymphoscintigraphy imaging be considered as an integral part of sentinel lymph node mapping in surgical oncology. Detailed results of lymphoscintigraphy images should be provided for surgeons prior to surgery, and in case the sentinel lymph nodes are not visualized, use of blue dye for sentinel node mapping should be encouraged.


Main Subjects

  1. Tarjan M. Sentinel lymph node biopsy in Hungary. Results with a revolutionary new method in surgical oncology. Magy Onkol. 2002;46 (4):315-21.
  2. Ellis LM. A perspective on sentinel lymph node biopsy in colorectal cancer: the race between surgical technology and molecular oncology. Ann Surg Oncol. 2000;7 (7):475-6.
  3. Snoj M, Golouh R, Movrin-Stanovnik T, Vidergar-Kralj B. Added value of blue dye in sentinel node biopsy for breast cancer. J Exp Clin Cancer Res. 2003;22 (4):551-5.
  4. Sadeghi R, Alesheikh G, Zakavi SR, Fattahi A, Abdollahi A, Assadi M, et al. Added value of blue dye injection in sentinel node biopsy of breast cancer patients: Do all patients need blue dye?. Int J Surg. 2014;12 (4):325-8.
  5. Ramin S, Azar FP, Malihe H. Methylene blue as the safest blue dye for sentinel node mapping: emphasis on anaphylaxis reaction. Acta Oncol. 2011;50 (5):729-31.
  6. Jangjoo A, Forghani MN, Mehrabibahar M, Sadeghi R. Anaphylaxis reaction of a breast cancer patient to methylene blue during breast surgery with sentinel node mapping. Acta Oncol. 2010;49 (6):877-8.
  7. Momennezhad M, Zakavi SR, Dabbagh Kakhki VR, Jangjoo A, Ghavamnasiri MR, Sadeghi R. Scatterogram: a method for outlining the body during lymphoscintigraphy without using external flood source. Radiol Oncol. 2011;45 (3): 184-8.
  8. Kang T, Yi M, Hunt KK, Mittendorf EA, Babiera GV, Kuerer H, et al. Does blue dye contribute to success of sentinel node mapping for breast cancer?. Ann Surg Oncol. 2010;17:280-5.
  9. Dang Y, Engel J. Patent blue dye and an atypical anaphylactic reaction after sentinel lymph node biopsy in early breast cancer. Breast J. 2012;18 (1): 91-2.
  10. Noirot A, Vigneau A, Salengro A, Bonnet F. Allergic reaction to patent blue dye for sentinel lymph node detection during uterus oncological surgery. Ann Fr Anesth Reanim. 2005;24 (5): 541-2.
  11. Jangjoo A, Shabani G, Zakavi R, Kakhki VRD, Sadeghi R. Disappearance of a sentinel node on the delayed lymphoscintigraphy imaging of a breast cancer patient: Importance of blue dye injection. Nowotwory. 2011;61 (1):30-1.
  12. Derossis AM, Fey J, Yeung H, Yeh SD, Heerdt AS, Petrek J, et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg. 2001;193 (5): 473-8.